D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections ; volume:8 ; number:1 ; day:18 ; month:6 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.6.2018), 1-10, 12.2018
- Urheber
-
Dartevelle, Pauline
- Beteiligte Personen und Organisationen
-
Ehlinger, Claire
Zaet, Abdurraouf
Boehler, Christian
Rabineau, Morgane
Westermann, Benoit
Strub, Jean-Marc
Cianferani, Sarah
Haïkel, Youssef
Metz-Boutigue, Marie-Hélène
Marban, Céline
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-27417-x
- URN
-
urn:nbn:de:101:1-2018082110255101337300
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dartevelle, Pauline
- Ehlinger, Claire
- Zaet, Abdurraouf
- Boehler, Christian
- Rabineau, Morgane
- Westermann, Benoit
- Strub, Jean-Marc
- Cianferani, Sarah
- Haïkel, Youssef
- Metz-Boutigue, Marie-Hélène
- Marban, Céline
- SpringerLink (Online service)
Ähnliche Objekte (12)
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment